Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Avery Dennison, 3M Settle Patent And Antitrust Litigation - Quick Facts

RELATED NEWS
Trade AVY now with 

Avery Dennison Corp. (AVY: Quote) announced the settlement of its patent and antitrust litigation with 3M company. Avery said the company will continue to sell its OmniCube products worldwide.

The litigation began when 3M alleged that Avery Dennison infringed its patents and sought a preliminary injunction to prevent Avery from selling OmniCube, a Type XI sheeting product used to increase nighttime visibility of road signs and other highway and transportation products. The court denied 3M's request, and after Avery Dennison brought claims of its own for patent infringement and antitrust violations, the companies agreed to dismiss all three pending cases.

Click here to receive FREE breaking news email alerts for Avery Dennison Corp. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Computer and printer maker Hewlett-Packard Co. (HPQ) said Wednesday after the markets closed that its third quarter profit fell 29% from last year, hurt mainly by higher restructuring charges even as revenue grew 1%. The company's quarterly earnings per share, excluding items, came in line with analysts' expectations, but its quarterly revenue beat analysts' forecast. Stocks fluctuated over the course of the trading day on Wednesday before ending the session mostly higher. The Dow and the S&P 500 both finished the day in positive territory, although the tech-heavy Nasdaq posted a modest loss. President Barack Obama spoke harshly of the terrorist group allegedly responsible for the execution of American freelance journalist James Foley in a statement on Wednesday. Obama described the group known as the Islamic State of Iraq and the Levant, or ISIL, as a cancer that needs to be extracted.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.